engleski

Prevalence of new oral anticoagulants use in patients admitted to university department of traumatology

New oral anticoagulants (NOAC) recently were introduced in the clinical practice as an alternative to warfarin for the prevention and treatment of thrombosis. Majority of published investigations dealt with comparison of NOAC efficacy in relation to warfarin but there is less information on how frequently these agents were prescribed in the clinical practice. The purpose of this study was to analyse frequency and trends of NOACs prescription in patients admitted to the University Department of Traumatology, Sestre Milosrdnice University Hospital Center in Zagreb, Croatia during last four years. Medical records of inpatients admitted to University Department of Traumatology, Sestre Milosrdnice University Hospital Centre from 1.1.2014 to 31.12.2017 were retrospectively reviewed. Data related to prescribed NOACs, including, direct thrombin and factor Xa inhibitors, age, gender and ICD-10 diagnosis on admission were recorded. We have recorded the increased trend of prescribing NOACs since 2014 indicating an uptake in their prescription in the patients with injuries and disorders of the knee and hip. However, further investigations should be performed in order to provide insight into optimal implementation of NOACs into everyday practice.

oral ; anticoagulants ; thrombosis

nije evidentirano